Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Drug delivery specialist Bioject Medical Technologies has entered into a three-year supply agreement with Merck Serono for the supply of the 'cool.click' and 'Serojet' spring-powered needle-free device for use with Merck Serono's recombinant human growth hormone drugs.
Subscribe to our email newsletter
Ralph Makar, the newly appointed president and CEO of Bioject, said: “We are pleased to enter into this new agreement with Merck Serono, which is the continuation of our successful relationship with them. Merck Serono has been an excellent partner and we appreciate the confidence Merck Serono has in our proprietary needle-free technology. We look forward to continuing to supply them with our value-added spring-powered device and disposables for their recombinant human growth hormone drugs.”